NCT06969768View on ClinicalTrials.gov

Proteogenomics for Follicular Cell-derived Thyroid Cancer: Development of a Classification and Prognosis Prediction Model

CompletedOBSERVATIONAL
Enrollment

275

Participants

Timeline

Start Date

February 21, 2018

Primary Completion Date

February 21, 2021

Study Completion Date

February 28, 2024

Conditions
Thyroid Cancer
Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors
collaborator

Korea Health Industry Development Institute

OTHER_GOV

collaborator

National Research Foundation of Korea

OTHER

lead

Seoul National University Hospital

OTHER

NCT06969768 - Proteogenomics for Follicular Cell-derived Thyroid Cancer: Development of a Classification and Prognosis Prediction Model | Biotech Hunter | Biotech Hunter